Opioid Treatment and Peer Recovery Support
JCOIN
Using Implementation Interventions and Peer Recovery Support to Improve Opioid Treatment Outcomes in Community Supervision
2 other identifiers
interventional
450
1 country
3
Brief Summary
Determine whether a facilitated local change team intervention improves a probation organization's client-level medication for opioid use disorder (MOUD) outcomes and implementation outcomes relative to baseline across multiple sites. Determine whether client-level outcomes are further enhanced by the introduction of Peer Support Services.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2021
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 2, 2021
CompletedFirst Submitted
Initial submission to the registry
May 25, 2021
CompletedFirst Posted
Study publicly available on registry
July 27, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2026
CompletedMay 13, 2025
May 1, 2025
4.8 years
May 25, 2021
May 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Individual-Level Experimental (Period 2) Outcome: Engagement in MOUD
Calculated from self-report survey of being enrolled in MOUD (yes or no) at each assessment.
26 weeks
Program-Level Implementation Outcome: Engagement in MOUD
MOUD engagement (primary implementation outcome) is defined as enrollment in MOUD treatment program, or filling a prescription for buprenorphine from a provider (in not on MOUD at time of recruitment), or remaining in MOUD treatment (if already on MOUD when recruited or at previous follow-up), coded dichotomously. Number of clients in probation enrolled in MOUD is tracked via medical and probation records.
26 weeks
Secondary Outcomes (8)
Detainment during Assessment Period (Individual-Level Experimental (Period 2) Outcome)
26 weeks
Opioid Use (Individual-Level Experimental (Period 2) Outcome)
26 weeks
Non-Fatal Overdose Events (Individual-Level Experimental (Period 2) Outcome)
26 weeks
Staff MOUD Knowledge and Attitudes (Program-Level Implementation Outcome)
26 weeks
Organizational Readiness for Change (Program-Level Implementation Outcome)
26 weeks
- +3 more secondary outcomes
Study Arms (3)
Implementation Core
EXPERIMENTALDuring baseline Exploration, staff organizational surveys are collected. During Preparation, staff focus groups conduct needs assessment with system mapping of linkage points for screening, assessment, and referral, and the agencies/staff involved in these activities. During Implementation, sites use facilitated local change teams (LCT) provided with a core set implementation strategies to facilitate linkages between probation agencies and local community treatment providers. The LCTs identify barriers to change, approaches to overcome barriers, do goal selection using SMART (specific, measurable, achievable, relevant, timely) goals and evidence for medications, address stigma, and clarify needs/expectations/roles of probation officers and treatment providers, then choose and implement goals and strategies. Sustainability Phase: Facilitators work with LCTs for 12 months using a written action plan based on goal selection.
Randomized Trial of Peer Support Specialist Model
EXPERIMENTALAfter Core implementation is complete, half of adult participants in probation who consent will be randomly assigned to a Peer Support Specialist (PSS) condition. PSS are assigned to adults diagnosed with OUD within 6 months of entry into probation, in addition to treatment as usual. PSS establish linkages to community providers (medical, mental health, substance use treatment); educate about recovery support services, transportation assistance, MOUD; provide experiential, non-clinical support to individuals with SUD; share skills, offer support for setting goals and navigating the recovery process); and provide referrals and support for treatment, housing, employment, drug court, and probation.
Randomized to Treatment as Usual
ACTIVE COMPARATORAfter Core Implementation is complete, half of adult participants in probation who consent will be randomly assigned to continue with usual care.
Interventions
Staff are provided with a core set of implementation strategies to facilitate interorganizational linkages between probation agencies and local community treatment providers.
Participants randomized to PSS will meet with a PSS for 6 months. Contact scheduled is flexible and based on the participant's needs and wants, plus written guidance for PSS-participant interactions.
Participants randomized to TAU will receive the services that will be offered at the time the Core Implementation intervention is completed.
Eligibility Criteria
You may qualify if:
- Community Provider Staff: Any front-line treatment provider at an agency participating in this study who: (a) provides support to MOUD clients, (b) has an active caseload including some individuals on probation, and (c) willing to commit to 12 months to the project.
- Probation/Parole Staff: Any probation officer (PO) at an agency participating in this study who (a) has an active caseload, and (b) is willing to commit to 12 months to the project.
- Individuals on Probation: (a) 18 years or older, (b) committed to probation within 90 days prior to study enrollment, (c) English speaking, (d) diagnosed with OUD, (e) have stable method of contact in community
You may not qualify if:
- Individuals on Probation: Currently incarcerated or in a court-mandated inpatient treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Brown Universitylead
- University of North Carolina, Chapel Hillcollaborator
- Temple Universitycollaborator
- University of Rhode Islandcollaborator
- The Miriam Hospitalcollaborator
- National Institute on Drug Abuse (NIDA)collaborator
- CODAC Behavioral Healthcarecollaborator
- Duke Universitycollaborator
Study Sites (3)
Duke University
Durham, North Carolina, 27708, United States
Temple University
Philadelphia, Pennsylvania, 19122, United States
Brown University
Providence, Rhode Island, 02912, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rosemarie A Martin, PhD
Brown University
- PRINCIPAL INVESTIGATOR
Damaris J Rohsenow, PhD
Brown University
- PRINCIPAL INVESTIGATOR
Lauren Brinkley-Rubinstein, PhD
Duke University
- PRINCIPAL INVESTIGATOR
Steven Belenko, PhD
Temple University
- PRINCIPAL INVESTIGATOR
Lynda Stein, PhD
University of Rhode Island
- PRINCIPAL INVESTIGATOR
Josiah Rich, MD
The Miriam Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 25, 2021
First Posted
July 27, 2021
Study Start
March 2, 2021
Primary Completion
December 30, 2025
Study Completion
April 30, 2026
Last Updated
May 13, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- The data will become available after the results of the primary study analyses have been accepted for publication. The data will be available for five years.
- Access Criteria
- De-identified data will be shared with the Methodology and Advanced Analytics Resource Center (MAARC) of JCOIN and with qualified researchers on request to the MAARC.
The coordinating center is charged with creating de-identified versions of agency staff and probation individual level data available at the end of the study.